Idexx Laboratories | Le Bénéfice D'Exploitation



Operating Profit Changement Date
Abbott USD 1.66B 253M 2025-03
Align Technology USD 144.15M 18.15M 2024-12
Dentsply International USD -509000000 47M 2024-12
Dexcom USD 188.9M 36.9M 2024-12
Edwards Lifesciences USD 312.6M 38M 2024-12
Fujifilm JPY 87.68B 14.26B 2024-12
Globus Medical USD 60.27M 12.18M 2024-12
Henry Schein USD 155M 2M 2024-12
Hologic USD 229.8M 200K 2024-12
Idexx Laboratories USD 261.69M 42.21M 2024-12
Insulet USD 109.3M 21.2M 2024-12
Integra LifeSciences USD 35.23M 43.36M 2024-12
Intuitive Surgical USD 734.9M 157.6M 2024-12
Masimo USD -359100000 389.2M 2024-12
Neogen USD 5.42M 462.9M 2025-02
Patterson Companies USD 45.44M 7.8M 2025-01
ResMed USD 417.24M 29.93M 2024-12
Roche Holding CHF 4.39B 1.04B 2024-12
Steris USD 245.4M 31.97M 2024-12
Tandem Diabetes Care USD -582000 25.51M 2024-12
Teleflex USD -110383000 259.69M 2024-12
Thermo Fisher Scientific USD 2.02B 178M 2024-12
Zoetis USD 732M 142M 2024-12



Idexx Laboratories Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.